Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 9/2019

01-09-2019 | Nausea | Author Correction

Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy

Authors: Giuseppe Badalamenti, Lorena Incorvaia, Carlo Messina, Emmanuela Musso, Alessandra Casarin, Maria Rita Ricciardi, Ida De Luca, Viviana Bazan, Antonio Russo

Published in: Supportive Care in Cancer | Issue 9/2019

Login to get access

Excerpt

Correction to: Supportive Care in Cancer …
Metadata
Title
Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy
Authors
Giuseppe Badalamenti
Lorena Incorvaia
Carlo Messina
Emmanuela Musso
Alessandra Casarin
Maria Rita Ricciardi
Ida De Luca
Viviana Bazan
Antonio Russo
Publication date
01-09-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 9/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04852-8

Other articles of this Issue 9/2019

Supportive Care in Cancer 9/2019 Go to the issue

Review Article

Are cancer helplines effective in supporting caregivers? A systematic review

Original Article

Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence

Original Article

One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients

Original Article

Managing malignant pleural mesothelioma: experience and perceptions of health care professionals caring for people with mesothelioma

Review Article

Pharmacological evidence of medicinal cannabis in oncology: a systematic review

Original Article

The association between patients’ perceived continuity of care and beliefs about oral anticancer treatment
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits